September 15, 2009 – St. Jude Medical Inc. said yesterday the U.S. Food and Drug Administration (FDA) cleared and U.S. launch of the EnSite Velocity Cardiac Mapping System, which is designed to help physicians more efficiently diagnose and guide therapy to treat abnormal heart rhythms.
September 15, 2009 - Positron Corp. announced that the Ministry of Health and Long Term Care of Ontario, Canada is making positron emission tomography (PET) scanning a publicly insured health service available to cancer and cardiac patients under conditions where PET scans have been proven to be clinically effective.
September 9, 2009 - Integrated backscatter (IBS) images were acquired with transesophageal echocardiography (TEE) and 3-dimensional image reconstruction to identify an increase in atrial degeneration that might predict the occurrence of atrial fibrillation (AF) before left atrium (LA) dilation.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 14, 2009 – The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) today featured four late breaking clinical trials at the Hynes Convention Center in Boston.
September 13, 2009 – Mayo Clinic researchers say that "teachable software" designed to mimic the human brain may help them diagnose cardiac infections without an invasive exam, according to findings being presented today at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco.
September 14, 2009 – OrbusNeich's Genous Bio-engineered R stent is feasible and safe in patients who need coronary revascularization before undeferrable noncardiac surgery and have to discontinue dual anti-platelet therapy, according to a paper published online in the International Journal of Cardiology.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Sept. 14, 2009 – Abbott said today the Chinese State Food and Drug Administration (SFDA) has approved the XIENCE V Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease (CAD) – the leading cause of death in China.
September 14, 2009 – InfraReDx said it will highlight its LipiScan Coronary Imaging System at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting, Sept. 21-25 in San Francisco. The LipiScan will be displayed in the emerging technologies section at booth 2410. InfraReDx events at TCT 2009 include:
September 14, 2009 - Coronary computed tomography angiography (CCTA) enables cardiac morphology with high and isotropic spatial resolution, according to a new study published in Journal of the American College of Cardiology, Volume 54, No. 13. September 22, 2009.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 11, 2009 – Abbott said yesterday it reached an $410 million agreement to purchase Evalve Inc., the global leader in the development of devices for minimally invasive repair of cardiac mitral valves.
September 11, 2009 – Terumo Interventional Systems yesterday launched its Glidewire Advantage Peripheral Guidewire, a single wire that enables the operator to both cross the lesion and deliver interventional devices such as balloons and stents.
September 11, 2009 – Terumo Interventional Systems yesterday announced the expansion of its Pinnacle Destination Guiding Sheaths with an 8 French size to extend the range of interventional procedures that can be performed, including atherectomy and stent graft procedures.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Gregg W. Stone, M.D., offered a preview Sept. 10 of some of the key, late-breaking clinical trials and trends in interventional cardiology that will be presented during the Transcatheter Therapeutics (TCT) 2009 Symposium Sept. 21-25 in San Francisco.
September 10, 2009 – Regado Biosciences said this week it enrolled the first patient in a phase 2b, randomized, partially-blinded, multicenter, active-controlled, dose-ranging study of its REG1 anticoagulation system.
September 10, 1009 - With the details over medical imaging equipment utilization rates and Medicare reimbursement cuts for diagnostic imaging still on the table, President Obama’s televised speech on healthcare reform last night drew reaction from advocate groups like the Medical Imaging and Technology Alliance (MITA).